Gerald Patrick Miletello MD

President of the Louisiana Oncology Society

7777 Hennessy BlvdSte 6000Baton Rouge, LA 70808
Phone+1 225-757-0343
Fax+1 225-757-8354

Dr. Miletello is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Miletello's full profile Already have an account?

Education & Training

Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1984
Louisiana State University School of MedicineResidency, Internal Medicine, 1981 - 1982
Ochsner Clinic FoundationResidency, Internal Medicine, 1981 - 1981
Louisiana State University School of Medicine in New OrleansClass of 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

LA State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MedSym EHR, MedSym, Inc., 2013-2015, 2017
CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2013-2015, 2017

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
COMPLETED
PHASE3
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
COMPLETED
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
TERMINATED
PHASE4

Publications & Presentations

PubMed

A randomized trial of a multimodal lifestyle intervention in cancer survivors.
Justin C Brown, Phillip Nauta, Darryl Whitehead, Benjamin R Dubin, Ryan Nash
Frontiers in Oncology. 2025-01-01
16 citations
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
Joseph I. Clark, Brendan Curti, Elizabeth J. Davis, Howard L. Kaufman, Asim Amin
Journal of Investigative Medicine. 2021-02-04
41 citations
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM re...
Mayer Fishman, Janice P. Dutcher, Joseph I. Clark, Ajjai Alva, Gerald P Miletello
Journal for Immunotherapy of Cancer. 2019-03-27

Press Mentions

Unnecessary Medicare Advantage Denials: Harming Louisiana Patients, Crowding Our Emergency Departments, and Costing U.S. Providers BillionsSeptember 18th, 2024
Baton Rouge General Partners with Hematology Oncology Clinic to Expand Cancer ProgramSeptember 28th, 2016